Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21957666 | 0.88 | CYP3A4 (0.71) | CYP3A4USP2MAPK1SMN1; SMN2HPGD | |
| SCHEMBL24379065 | 0.88 | GAA (0.54) | CYP3A4USP2MAPK1SMN1; SMN2HPGD | |
| SCHEMBL2027170 | 0.88 | CYP3A4 (0.69) | CYP3A4USP2MAPK1SMN1; SMN2HPGD | |
| SCHEMBL9699067 | 0.87 | CYP3A4 (0.58) | CYP3A4USP2MAPK1SMN1; SMN2ABCG2 | |
| SCHEMBL1012543 | 0.87 | KDM4E (0.51) | CYP3A4USP2MAPK1SMN1; SMN2HPGD | |
| Phosphine SCHEMBL22499896 | 0.85 | CYP3A4 (0.56) | CYP3A4USP2MAPK1SMN1; SMN2ABCG2 | |
| SCHEMBL2801743 | 0.84 | ALDH1A1 (0.50) | CYP3A4USP2MAPK1SMN1; SMN2HPGD | |
| SCHEMBL7956511 | 0.83 | CYP3A4 (0.55) | CYP3A4USP2MAPK1SMN1; SMN2ABCG2 | |
| SCHEMBL8330318 | 0.83 | POLB (0.53) | CYP3A4SMN1; SMN2HPGDKMT2ACA1 | |
| SCHEMBL28776697 | 0.82 | CYP3A4 (0.46) | CYP3A4USP2MAPK1SMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170128595-A1 | MICROBIAL GROWTH INDICATING MEDICAL DEVICES | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2017-05-11 | — | — | US | disclosed |
| EP-3158080-A1 | MICROBIAL GROWTH INDICATING MEDICAL DEVICES | Indicator Systems International, Inc. (US) | 2017-04-26 | — | — | EP | disclosed |
| US-9581861-B2 | Phase difference film, polarizing plate, and liquid crystal display device | Konica Minolta, Inc. (JP) | 2017-02-28 | — | — | US | disclosed |
| WO-2015200229-A1 | MICROBIAL GROWTH INDICATING MEDICAL DEVICES | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2015-12-30 | — | — | WO | disclosed |
| US-9115066-B2 | Trisubstituted methyl alcohols and their polymerizable derivatives | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2015-08-25 | — | — | US | disclosed |
| US-8979260-B1 | Contact lenses with indicators | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2015-03-17 | — | — | US | disclosed |
| US-20150037258-A1 | INFECTION INDICATING MEDICAL DEVICES | INDICATOR SYSTEMS INTERNATIONAL, INC. | 2015-02-05 | — | — | US | disclosed |
| EP-2814803-A1 | TRISUBSTITUTED METHYL ALCOHOLS AND THEIR POLYMERIZABLE DERIVATIVES | Indicator Systems International, Inc. (US) | 2014-12-24 | — | — | EP | disclosed |
| WO-2014182854-A2 | INFECTION INDICATING MEDICAL DEVICES | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2014-11-13 | — | — | WO | disclosed |
| US-20130202531-A1 | INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS | INDICATOR SYSTEMS INTERNATIONAL, INC. | 2013-08-08 | — | — | US | disclosed |
| WO-2013090682-A1 | TRISUBSTITUTED METHYL ALCOHOLS AND THEIR POLYMERIZABLE DERIVATIVES | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2013-06-20 | — | — | WO | disclosed |
| US-8425996-B2 | Indicators for detecting the presence of metabolic byproducts from microorganisms | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2013-04-23 | — | — | US | disclosed |
| US-20120316408-A1 | INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BY-PRODUCTS FROM MICROORGANISMS | INDICATOR SYSTEMS INTERNATIONAL, INC. | 2012-12-13 | — | — | US | disclosed |
| WO-2012158467-A2 | INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BY-PRODUCTS FROM MICROORGANISMS | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2012-11-22 | — | — | WO | disclosed |
| CN-102405131-A | Indicator for detecting the presence of microbial metabolic byproducts | INDICATOR SYSTEMS INTERNATIONA | 2012-04-04 | — | — | CN | disclosed |
| EP-2382080-A1 | INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS | Indicator Systems International, Inc. (US) | 2011-11-02 | — | — | EP | disclosed |
| US-20100196636-A1 | INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS | INDICATOR SYSTEMS INTERNATIONAL, INC. | 2010-08-05 | — | — | US | disclosed |
| WO-2010085755-A1 | INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS | INDICATOR SYSTEMS INTERNATIONAL, INC. (US) | 2010-07-29 | — | — | WO | disclosed |
| US-6245779-B1 | ANALGESICS; ANTIINFLAMMATORY AGENTS | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2001-06-12 | — | — | US | disclosed |
| EP-0997463-A1 | NAPHTHYRIDINE DERIVATIVES | OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) | 2000-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100196636-A1 | INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS | PGLS, MGAM, G6PD | CYP3A4 311/4885USP2 1251/4885MAPK1 3004/4885 |
| US-20170128595-A1 | MICROBIAL GROWTH INDICATING MEDICAL DEVICES | MKI67, MGAM, AREG | CYP3A4 2261/4885USP2 848/4885MAPK1 1995/4885 |
| US-20150037258-A1 | INFECTION INDICATING MEDICAL DEVICES | CUTA, CD63, CD99 | CYP3A4 1301/4885USP2 468/4885MAPK1 2093/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.